A Pragmatic Approach to Monitor for Adrenal Axis Recovery After a Failed Short Synacthen Test.

Journal: Endocrine Practice : Official Journal Of The American College Of Endocrinology And The American Association Of Clinical Endocrinologists
Published:
Abstract

Objective: To identify a morning cortisol threshold value which confirms non-recovery of the adrenal axis and therefore negates the need for a short Synacthen test (SST) in those with known adrenal axis insufficiency.

Methods: We collected data from all SSTs (n = 1570 tests; n = 952 individuals) conducted in our hospital over a 10-year period spanning between 1st February, 2013, and 30th January, 2023. We included all tests where baseline cortisol levels were taken before 9:30 am Both 30- and 60-minute cortisol values were measured. Cortisol was measured using the Abbott Architect method. We used the full SST dataset to construct a quantile regression model to predict the 95% centile of peak cortisol response. This model was refitted to the SST follow-up data for those who failed a first SST (n = 115 tests; n = 66 individuals) to identify the baseline cortisol value below which there was a less than 5% chance of passing an SST.

Results: Those with an early morning cortisol of ≤126 nmol/L had ≥95% chance of failing an SST. Sixty percent of follow-up SSTs (69/115) exhibited baseline cortisol values below this threshold, and none of these passed an SST.

Conclusions: An early morning cortisol ≤126 nmol/L is common in those followed for adrenal axis recovery and is an accurate indicator of non-recovery. Baseline cortisol measurements are therefore a simple way of screening for adrenal axis recovery. Those with a cortisol of >126 nmol/L should go on to have an SST. Using this approach could considerably reduce the need for follow up SSTs in this patient cohort.

Authors
Anes Harid, Matthew Rowe, Nishchil Patel, Jinny Jeffery, Daniel Flanagan, Andrew Mcgovern
Relevant Conditions

Addison's Disease